ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,627Medicare Part D Prescriptions Filled, Including Refills

Rank: 140 out of 1278

$371K Total Retail Price of All Prescriptions

Rank: 254 out of 1278

439 Patients Receiving at Least One Drug in Part D
60%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 439 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

10% of this provider’s 439 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 5,422 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LISINOPRIL 499 356 1 1
LEVOTHYROXINE SODIUM 471 351 2 2
ATENOLOL 380 251 3 11
SIMVASTATIN 315 223 4 3
OMEPRAZOLE 287 157 5 6
PRAVASTATIN SODIUM 286 167 6 14
AMLODIPINE BESYLATE 236 171 7 5
METFORMIN HCL 228 148 8 4
HYDROCODONE-ACETAMINOPHEN 185 131 S3 9 7
RANITIDINE HCL 162 40 10 20
IBUPROFEN 144 73 11 46
OXYCODONE-ACETAMINOPHEN 134 70 S2 12 29
GABAPENTIN 127 66 13 12
JANUVIA 123 70 14 68
FUROSEMIDE 120 92 15 10
OXYCODONE HCL 118 58 S2 16 27
PROAIR HFA 111 56 17 26
TRAMADOL HCL 109 38 18 25
HYDROCHLOROTHIAZIDE 108 86 19 8
LOSARTAN POTASSIUM 106 95 20 19
ALENDRONATE SODIUM 104 87 21 18
GLYBURIDE 103 71 R 22 40
LANTUS 92 66 23 33
DIOVAN 87 83 24 44
LOVASTATIN 81 57 25 13
METOPROLOL TARTRATE 81 69 25 9
ZOLPIDEM TARTRATE 75 34 27 16
SERTRALINE HCL 74 62 28 28
AMITRIPTYLINE HCL 70 39 R 29 55
CYCLOBENZAPRINE HCL 69 16 R 30 62
POTASSIUM CHLORIDE 65 36 31 21
CITALOPRAM HBR 64 38 32 22
FLUTICASONE PROPIONATE 60 36 33 24
ADVAIR DISKUS 58 23 34 49
FLUOXETINE HCL 58 30 34 41
NAPROXEN 57 52 36 70
INSULIN SYRINGE 56 23 37 50
METFORMIN HCL ER 55 26 38 66
CARVEDILOL 54 22 39 39
AZITHROMYCIN 51 37 40 37
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 11, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.